Changes to the Natural Killer Cell Repertoire after Therapeutic Hepatitis B DNA Vaccination

por Scott-Algara, Daniel, Mancini-Bourgine, Maryline, Fontaine, Hélène, Pol, Stanislas, Michel, Marie-Louise
Publicado 2010

TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

por Martin, Perrine, Dubois, Clarisse, Jacquier, Emilie, Dion, Sarah, Mancini-Bourgine, Maryline, Godon, Ophélie, Kratzer, Roland, Lelu-Santolaria, Karine, Evlachev, Alexei, Meritet, Jean-François, Schlesinger, Yasmin, Villeval, Dominique, Strub, Jean-Marc, Van Dorsselaer, Alain, Marchand, Jean-Baptiste, Geist, Michel, Brandely, Renée, Findeli, Annie, Boukhebza, Houda, Menguy, Thierry, Silvestre, Nathalie, Michel, Marie-Louise, Inchauspé, Geneviève
Publicado 2015